Neurocysticercosis: An Update
- 23 October 2014
- journal article
- Published by Springer Nature in Current Infectious Disease Reports
- Vol. 16 (11) , 1-9
Abstract
Neurocysticercosis (NCC) is the most common helminthic disease of the nervous system in humans and a major cause of acquired epilepsy worldwide. The presentation of the disease is dependent on both the immunological response of the host against the parasite as well as the location of the encysted organisms within the central nervous system (CNS). The principles of management utilized for intraparenchymal disease cannot be applied to extraparenchymal NCC. An advance in management of intraparenchymal NCC, the most common form encountered by physicians, is the use of both albendazole and praziquantel as a treatment strategy. Patients with subarachnoid NCC (SANCC) require months of treatment with both an antiparasitic agent and steroids to avoid complications such as hydrocephalus and vascular events during treatment. The determinants of successful treatment in SANCC have not been established, but response to therapy can be determined by evaluating several endpoints related to disease evolution including radiographic changes, serum antigen, and CSF antigen. Intraventricular NCC is primarily a surgical disease and data supports minimally invasive endoscopic removal of cysts in many of these patients. NCC is increasingly recognized in non-endemic countries due to increased immigration making it important for physicians to become familiar with the management of this disease.Keywords
This publication has 95 references indexed in Scilit:
- Neurocysticercosis: Neglected but Not ForgottenPLOS Neglected Tropical Diseases, 2012
- Diagnosis and treatment of neurocysticercosisNature Reviews Neurology, 2011
- A Calcified Taenia solium Granuloma Associated with Recurrent Perilesional Edema Causing Refractory Seizures: Histopathological FeaturesThe American Journal of Tropical Medicine and Hygiene, 2011
- Clinical Manifestations Associated with Neurocysticercosis: A Systematic ReviewPLOS Neglected Tropical Diseases, 2011
- Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosisBritish Journal of Clinical Pharmacology, 2011
- A diagnostic and therapeutic scheme for a solitary cysticercus granulomaNeurology, 2010
- Taenia solium Cysticercosis Hotspots Surrounding Tapeworm Carriers: Clustering on Human Seroprevalence but Not on SeizuresPLOS Neglected Tropical Diseases, 2009
- Detection of HP10 antigen in serum for diagnosis and follow-up of subarachnoidal and intraventricular human neurocysticercosisJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Intramedullary cysticercosisSurgical Neurology, 1986
- Therapy of Parenchymal Brain Cysticercosis with PraziquantelNew England Journal of Medicine, 1984